Immunomodulatory peptide raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2026-08-01 and is reviewed periodically as new material appears.
Thymosin alpha 1 is a synthetic 28-amino-acid peptide first isolated in 1966 from thymosin fraction 5, a bovine thymus extract. Its chain begins with an acetylated serine residue and ends with asparagine. The native peptide carries a molecular mass near 3,108 daltons. Researchers classify it as an immunomodulatory agent rather than a hormone with a single endocrine target. Early work framed it as a thymus-derived factor that supports T-cell maturation. The synthetic form used in research and clinical products matches the natural sequence.
Immune signaling studies link thymosin alpha 1 to Toll-like receptor pathways, particularly TLR2 and TLR9, on dendritic cells and other antigen-presenting cells. Activation of these receptors promotes maturation of T cells and increases natural killer cell activity. The peptide shifts cytokine output toward a T helper 1 profile, raising interferon gamma and interleukin 2 while modulating interleukin 10. Whether these effects translate into clinical benefit for any specific disease remains a subject of debate. Reported outcomes vary across trials and populations.
Thymosin alpha 1 is approved as a medicine in several countries, including Italy and China, for indications such as chronic hepatitis B and as an immune adjuvant. It is not approved by the United States Food and Drug Administration as a therapeutic product. In research settings the peptide appears in studies of sepsis, vaccine response, and oncology support, often with mixed or inconclusive results. The evidence base is uneven, and reviews note that many trials were small. Regulatory status therefore differs widely between jurisdictions.
Thymosin alpha-1 is supplied as a lyophilized powder in most research settings. The solid dissolves readily in water and in common aqueous buffers, and it is typically reconstituted shortly before use. Solutions are clear and colourless at ordinary working concentrations. Because the peptide is hygroscopic, weighing and reconstitution are usually performed with minimal exposure to ambient air. Aliquots are prepared to avoid repeated freeze-thaw cycles, and working solutions are kept cold.
Long-term storage is generally at minus twenty degrees Celsius or colder, preferably desiccated and protected from light. Lyophilized material is more stable than reconstituted solution, which degrades faster at room temperature. Stability depends on pH, ionic strength, and the presence of oxidising agents. Published stability data for the peptide are limited, so storage claims in catalogues should be treated as general guidance rather than measured guarantees. Freeze-thaw cycles are kept to a minimum.
| Property | Value | Notes |
|---|---|---|
| Molecular mass | ≈3,108 Da | Synthetic 28-residue peptide |
| Amino acid count | 28 | N-terminal serine carries an acetyl group |
| Appearance | White to off-white powder | Lyophilized solid |
| Water solubility | Freely soluble | Dissolves in aqueous buffer |
| Common synonyms | Thymalfasin; Tα1 | Thymalfasin is the international nonproprietary name |
Thymosin alpha 1 is a short peptide first isolated from bovine thymus tissue in the early 1970s during fractionation work aimed at identifying factors that influence T cell development. It belongs to a family of acidic thymic peptides, and the original preparations contained several components that were later separated by chromatography. The compound is now produced synthetically rather than extracted from tissue, which removes batch variability tied to animal sourcing. Researchers describe it as an immunomodulatory peptide because laboratory studies show effects on several cell types of the innate and adaptive immune systems.
The molecule consists of 28 amino acid residues with an acetyl group attached to the N-terminal serine. Its sequence is acidic overall, with several glutamic and aspartic acid residues distributed along the chain and no cysteine, so disulfide bridges do not form. The peptide carries a net negative charge at physiological pH. Because the N-terminus is blocked, the intact molecule resists degradation by many aminopeptidases, which contributes to its stability in biological fluids.
Identity and purity testing for thymosin alpha 1 relies mainly on reversed-phase high-performance liquid chromatography and mass spectrometry. Chromatography separates the parent peptide from truncated or modified variants, while mass spectrometry confirms the expected molecular mass. Amino acid analysis and peptide mapping provide additional sequence confirmation. Counterion content, water content, and residual solvents are measured separately as part of specification testing. No single method captures every attribute, so laboratories combine several techniques.
The peptide lacks cysteine, methionine, and tryptophan, so disulfide scrambling and sulfur oxidation are not major degradation routes. Instead, aspartate residues can undergo isomerization or cyclization to succinimide intermediates, generating isoaspartate variants. Hydrolysis of peptide bonds also occurs slowly in solution. These changes may reduce biological activity even when the main peak remains detectable. Stability studies therefore track both potency and the appearance of related substances.
市售的胸腺素α1通常以冻干粉形式提供，溶解后用于注射。其氨基酸组成包括多个酸性残基，因此在中性pH下带负电荷。该肽可溶于水和生理盐水，但在有机溶剂中溶解度有限。储存条件通常为冻干状态下负20摄氏度，溶解后需冷藏并避免反复冻融。常见的同义词包括胸腺肽α1、thymalfasin和Tα1。
胸腺素α1（thymosin alpha 1，Tα1）是一种由28个氨基酸组成的酸性肽，N端被乙酰化，分子量约为3108道尔顿。该肽最早从牛胸腺组织提取物中分离，属于胸腺素组分5的一个成分。其序列在不同哺乳动物中高度保守，提示其具有基本的生物学功能。名称中的“α1”指其在电泳中的迁移位置，并非表示亚型编号。它既存在于胸腺，也存在于脾脏和淋巴结等免疫组织。
20世纪70年代，研究者从胸腺提取物中纯化出多种小肽，Tα1是其中被较早表征的一种。最初的制备依赖组织匀浆和层析步骤，产量低且成分复杂。随着固相肽合成技术成熟，实验室和工业界能够生产与天然序列一致的合成版本。合成肽的纯度可达95%以上，并可通过反相高效液相色谱和质谱进行鉴定。这一转变使研究不再依赖动物胸腺来源。
==== Corporate card ==== According to the Federal Court of Accounts (TCU), between January 2023 and April 2025 more than 55 million reais were spent by the Presidency with corporate cards. According to VEJA, of the entire amount, 99.55 percent are expenses classified as confidential, which prevents oversight bodies from evaluating how the amounts are being spent.
==== Non-peptide ==== CA7 – among smallest-known oxytocin receptor agonists; considerable selectivity over the vasopressin V1A receptor KNX-200 (KNX200) – series; chemical structure(s) not yet disclosed LIT-001 — improved social deficits in mice; non-selective over vasopressin receptors LIT-002 – extremely potent; improved social deficits in mice; non-selective over vasopressin receptors TC OT 39 – non-selective over vasopressin receptors WAY-267,464 – anxiolytic in mice; possibly non-selective over vasopressin receptors WJ0679 – among smallest-known oxytocin receptor agonists; produces prosocial effects in rodents
Before the 20th century crystallography was not a well-established academic discipline. There were no academic positions specifically in crystallography. Workers in the field normally carried out their crystallographic research as an ancillary to other employment(s), or had independent means. The leading workers in the field of chemical crystallography were employed as follows:
Sources: en.wikipedia.org
PP cells are able to produce pancreatic polypeptide through transcription and translation of the PPY gene. Once it is produced, pancreatic polypeptide is shown to be a 36 amino acid long peptide that can be sent out to different areas within the pancreas or organism. Pancreatic polypeptide cells are most active and secrete more pancreatic polypeptide after a meal with high protein, fasting, physical activity, and acute hypoglycemia. These same cells are inhibited by somatostatin, an inhibitory gastrointestinal hormone, and the presence of glucose.
=== Human Diseases and Gene Mutations === Greenspan has conducted various research projects directly on the molecular bases of human diseases. A collaborative study with a group at Jefferson Medical College showed mutations in the COL7A1 gene, for type VII collagen, to be the basis of the disabling and fatal skin disease dystrophic epidermolysis bullosa These studies also led to elucidation of the complete intron-exon structure of COL7A1 which at the time had more exons than any previously described gene. His lab was the first to clone and characterize the α1 chain of type V collagen and was also key in the first demonstration that mutations in a type V collagen gene can cause the heritable connective tissue disorder classic Ehers-Danlos syndrome. Accompanying and following these studies, the Greenspan lab has performed studies on collagen V genes and on the biosynthesis of type V collagen and on the molecular mechanisms whereby mutations in type V collagen result in defects in mammalian tissues. Their studies have also shown autoimmunity against type V collagen to be involved in organ transplant rejection and atherosclerosis, and that induction of immune tolerance to type V collagen can help ameliorate atherosclerosis. The Greenspan lab was also the first to clone and characterize the α3 chain of type V collagen and showed the α3(V) chain to be important to the functioning of certain highly specialized cell types and to be important to tumor growth and survival times in breast cancer.
"David J. Gross, a celebrated U.S. theoretical physicist, calls himself an optimist—especially concerning the future of his field. He's certain that somewhere out there lurks a final, unified theory of nature, just waiting to be discovered. But ... he estimates it's more likely that we'll destroy ourselves in nuclear warfare first. And [as a Nobel laureate in physics and] as the latest recipient of a $3-million Special Breakthrough Prize in Fundamental Physics, he's using the opportunity to warn the world of this dire peril. [p. 90.] [Says Gross:] 'I'd estimate that the annual chance for nuclear war is now 2 percent.'" (p. 93.) Jerry Brown, 'I Taste Ashes in the Wind' (review of Serhii Plokhy, The Nuclear Age: An Epic Race for Arms, Power, and Survival, Norton, 422 pp.; David Holloway, Nuclear Weapons: An International History, Yale University Press, 708 pp.; Daniel Ellsberg, edited by Michael Ellsberg and Jan R. Thomas, Truth and Consequence: Reflections on Catastrophe, Civil Resistance, and Hope, Bloomsbury, 363 pp.), The New York Review of Books, vol. LXIX, no. 15 (8 October 2026), pp. 18, 20–21. Reviewer Jerry Brown writes: "Congress is now considering Trump's Golden Dome, a trillion-dollar scheme to place an ineffective missile defense 'shield' over the entire [United States]. ... Our leaders are complacent or distracted with respect to the risks of nuclear horror. They are men driven by grievance and whim. The public is uninformed or else desensitized. ...
Sources: en.wikipedia.org
It is a chain of 28 amino acids, with an acetyl group attached to the first serine residue. The synthetic version replicates this sequence. Its molecular mass is about 3,108 daltons.
It is usually described as an immunomodulatory peptide rather than a classic hormone. It acts on immune cells through receptor pathways. No single endocrine organ target defines its function.
Several countries, including Italy and China, allow it for specific indications. The FDA has not approved it as a drug in the United States. Availability depends on local regulation.
Lyophilized powder is normally kept at minus twenty degrees Celsius or below, in a sealed container, desiccated and away from light. Reconstituted solutions are less stable and are usually refrigerated and used quickly. Repeated temperature cycling should be avoided.